AU Stock MarketDetailed Quotes

CSL CSL Ltd

Watchlist
  • 282.350
  • +1.600+0.57%
20min DelayMarket Closed Dec 27 16:00 AET
136.72BMarket Cap34.56P/E (Static)

CSL Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
(FY)Jun 30, 2015
Total revenue
11.51%14.69B
25.55%13.17B
2.22%10.49B
12.80%10.27B
6.94%9.1B
12.15%8.51B
14.69%7.59B
11.95%6.62B
8.26%5.91B
2.32%5.46B
Operating revenue
11.51%14.69B
25.55%13.17B
2.22%10.49B
12.80%10.27B
6.94%9.1B
12.15%8.51B
14.69%7.59B
11.95%6.62B
8.26%5.91B
2.32%5.46B
Cost of revenue
10.25%7.13B
33.88%6.47B
8.12%4.83B
13.82%4.47B
4.34%3.92B
6.50%3.76B
6.16%3.53B
9.62%3.33B
16.46%3.03B
0.07%2.61B
Gross profit
12.72%7.56B
18.44%6.71B
-2.33%5.66B
12.03%5.8B
9.00%5.18B
17.07%4.75B
23.33%4.06B
14.41%3.29B
0.77%2.87B
4.46%2.85B
Operating expense
4.15%4.8B
37.60%4.61B
4.33%3.35B
9.52%3.21B
10.60%2.93B
15.16%2.65B
15.67%2.3B
6.72%1.99B
30.32%1.86B
-1.93%1.43B
Selling and administrative expenses
-4.37%2.43B
54.06%2.54B
-3.69%1.65B
7.80%1.71B
10.16%1.59B
10.81%1.44B
10.09%1.3B
14.83%1.18B
30.97%1.03B
-1.36%785.8M
-Selling and marketing expense
8.18%1.57B
51.35%1.45B
-1.99%960.7M
9.37%980.2M
3.39%896.2M
10.25%866.8M
12.80%786.2M
12.26%697M
24.60%620.9M
-1.33%498.3M
-General and administrative expense
-21.18%856M
57.85%1.09B
-5.97%688M
5.77%731.7M
20.35%691.8M
11.66%574.8M
6.19%514.8M
18.74%484.8M
42.02%408.3M
-1.41%287.5M
Research and development costs
15.79%1.43B
6.82%1.24B
15.46%1.16B
8.64%1B
10.82%921.8M
18.42%831.8M
8.85%702.4M
5.13%645.3M
32.66%613.8M
-0.79%462.7M
Depreciation amortization depletion
12.88%938M
53.18%831M
9.53%542.5M
17.98%495.3M
11.83%419.8M
26.53%375.4M
83.83%296.7M
-26.74%161.4M
21.51%220.3M
-6.98%181.3M
-Depreciation and amortization
12.88%938M
53.18%831M
9.53%542.5M
17.98%495.3M
11.83%419.8M
26.53%375.4M
83.83%296.7M
-26.74%161.4M
21.51%220.3M
-6.98%181.3M
Other operating expenses
----
----
----
----
--100K
----
----
----
----
----
Operating profit
31.49%2.76B
-9.24%2.1B
-10.58%2.32B
15.30%2.59B
6.98%2.25B
19.57%2.1B
35.04%1.76B
28.58%1.3B
-28.92%1.01B
11.78%1.42B
Net non-operating interest income (expenses)
-7.64%-437M
-152.80%-406M
3.77%-160.6M
-16.06%-166.9M
11.72%-143.8M
-64.38%-162.9M
-25.28%-99.1M
-37.09%-79.1M
-31.14%-57.7M
-33.74%-44M
Non-operating interest income
2.63%39M
118.39%38M
346.15%17.4M
-44.29%3.9M
-49.28%7M
48.39%13.8M
-14.68%9.3M
-21.58%10.9M
-10.90%13.9M
-22.39%15.6M
Non-operating interest expense
2.94%420M
185.71%408M
-16.39%142.8M
13.26%170.8M
-14.66%150.8M
63.01%176.7M
20.44%108.4M
25.70%90M
20.13%71.6M
12.45%59.6M
Total other finance cost
55.56%56M
2.27%36M
--35.2M
----
----
----
----
----
----
----
Other net income (expenses)
-19.12%110M
66.67%136M
82.55%81.6M
-11.13%44.7M
75.26%50.3M
-91.23%28.7M
6.64%327.4M
-19.61%307M
148.31%381.9M
-9.21%153.8M
Other non-operating income (expenses)
-19.12%110M
66.67%136M
82.55%81.6M
-11.13%44.7M
75.26%50.3M
-91.23%28.7M
6.64%327.4M
-19.61%307M
148.31%381.9M
-9.21%153.8M
Income before tax
26.74%3.38B
-4.19%2.66B
-6.19%2.78B
15.17%2.96B
9.89%2.57B
2.63%2.34B
35.00%2.28B
8.61%1.69B
-9.22%1.56B
6.84%1.71B
Income tax
57.76%661M
-20.18%419M
-10.75%524.9M
25.07%588.1M
11.32%470.2M
-23.52%422.4M
56.73%552.3M
12.41%352.4M
-6.42%313.5M
12.68%335M
Earnings from equity interest net of tax
Net income
20.94%2.71B
-0.47%2.24B
-5.07%2.25B
12.96%2.38B
9.58%2.1B
10.98%1.92B
29.27%1.73B
7.65%1.34B
-9.91%1.24B
5.51%1.38B
Net income continuous operations
20.94%2.71B
-0.47%2.24B
-5.07%2.25B
12.96%2.38B
9.58%2.1B
10.98%1.92B
29.27%1.73B
7.65%1.34B
-9.91%1.24B
5.51%1.38B
Noncontrolling interests
44.00%72M
50M
Net income attributable to the company
20.42%2.64B
-2.69%2.19B
-5.07%2.25B
12.96%2.38B
9.58%2.1B
10.98%1.92B
29.27%1.73B
7.65%1.34B
-9.91%1.24B
5.51%1.38B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
20.42%2.64B
-2.69%2.19B
-5.07%2.25B
12.96%2.38B
9.58%2.1B
10.98%1.92B
29.27%1.73B
7.65%1.34B
-9.91%1.24B
5.51%1.38B
Diluted earnings per share
20.22%5.47
-5.41%4.55
-7.85%4.81
12.67%5.22
9.37%4.633
10.83%4.236
30.13%3.822
9.22%2.937
-8.01%2.689
8.22%2.923
Basic earnings per share
20.31%5.45
-5.62%4.53
-7.87%4.8
12.89%5.21
9.20%4.615
10.95%4.226
29.96%3.809
9.24%2.931
-8.21%2.683
8.62%2.923
Dividend per share
7.32%2.4626
5.21%2.2946
4.44%2.181
10.47%2.0882
6.37%1.8902
19.32%1.777
13.06%1.4893
4.02%1.3172
11.61%1.2663
7.29%1.1345
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016(FY)Jun 30, 2015
Total revenue 11.51%14.69B25.55%13.17B2.22%10.49B12.80%10.27B6.94%9.1B12.15%8.51B14.69%7.59B11.95%6.62B8.26%5.91B2.32%5.46B
Operating revenue 11.51%14.69B25.55%13.17B2.22%10.49B12.80%10.27B6.94%9.1B12.15%8.51B14.69%7.59B11.95%6.62B8.26%5.91B2.32%5.46B
Cost of revenue 10.25%7.13B33.88%6.47B8.12%4.83B13.82%4.47B4.34%3.92B6.50%3.76B6.16%3.53B9.62%3.33B16.46%3.03B0.07%2.61B
Gross profit 12.72%7.56B18.44%6.71B-2.33%5.66B12.03%5.8B9.00%5.18B17.07%4.75B23.33%4.06B14.41%3.29B0.77%2.87B4.46%2.85B
Operating expense 4.15%4.8B37.60%4.61B4.33%3.35B9.52%3.21B10.60%2.93B15.16%2.65B15.67%2.3B6.72%1.99B30.32%1.86B-1.93%1.43B
Selling and administrative expenses -4.37%2.43B54.06%2.54B-3.69%1.65B7.80%1.71B10.16%1.59B10.81%1.44B10.09%1.3B14.83%1.18B30.97%1.03B-1.36%785.8M
-Selling and marketing expense 8.18%1.57B51.35%1.45B-1.99%960.7M9.37%980.2M3.39%896.2M10.25%866.8M12.80%786.2M12.26%697M24.60%620.9M-1.33%498.3M
-General and administrative expense -21.18%856M57.85%1.09B-5.97%688M5.77%731.7M20.35%691.8M11.66%574.8M6.19%514.8M18.74%484.8M42.02%408.3M-1.41%287.5M
Research and development costs 15.79%1.43B6.82%1.24B15.46%1.16B8.64%1B10.82%921.8M18.42%831.8M8.85%702.4M5.13%645.3M32.66%613.8M-0.79%462.7M
Depreciation amortization depletion 12.88%938M53.18%831M9.53%542.5M17.98%495.3M11.83%419.8M26.53%375.4M83.83%296.7M-26.74%161.4M21.51%220.3M-6.98%181.3M
-Depreciation and amortization 12.88%938M53.18%831M9.53%542.5M17.98%495.3M11.83%419.8M26.53%375.4M83.83%296.7M-26.74%161.4M21.51%220.3M-6.98%181.3M
Other operating expenses ------------------100K--------------------
Operating profit 31.49%2.76B-9.24%2.1B-10.58%2.32B15.30%2.59B6.98%2.25B19.57%2.1B35.04%1.76B28.58%1.3B-28.92%1.01B11.78%1.42B
Net non-operating interest income (expenses) -7.64%-437M-152.80%-406M3.77%-160.6M-16.06%-166.9M11.72%-143.8M-64.38%-162.9M-25.28%-99.1M-37.09%-79.1M-31.14%-57.7M-33.74%-44M
Non-operating interest income 2.63%39M118.39%38M346.15%17.4M-44.29%3.9M-49.28%7M48.39%13.8M-14.68%9.3M-21.58%10.9M-10.90%13.9M-22.39%15.6M
Non-operating interest expense 2.94%420M185.71%408M-16.39%142.8M13.26%170.8M-14.66%150.8M63.01%176.7M20.44%108.4M25.70%90M20.13%71.6M12.45%59.6M
Total other finance cost 55.56%56M2.27%36M--35.2M----------------------------
Other net income (expenses) -19.12%110M66.67%136M82.55%81.6M-11.13%44.7M75.26%50.3M-91.23%28.7M6.64%327.4M-19.61%307M148.31%381.9M-9.21%153.8M
Other non-operating income (expenses) -19.12%110M66.67%136M82.55%81.6M-11.13%44.7M75.26%50.3M-91.23%28.7M6.64%327.4M-19.61%307M148.31%381.9M-9.21%153.8M
Income before tax 26.74%3.38B-4.19%2.66B-6.19%2.78B15.17%2.96B9.89%2.57B2.63%2.34B35.00%2.28B8.61%1.69B-9.22%1.56B6.84%1.71B
Income tax 57.76%661M-20.18%419M-10.75%524.9M25.07%588.1M11.32%470.2M-23.52%422.4M56.73%552.3M12.41%352.4M-6.42%313.5M12.68%335M
Earnings from equity interest net of tax
Net income 20.94%2.71B-0.47%2.24B-5.07%2.25B12.96%2.38B9.58%2.1B10.98%1.92B29.27%1.73B7.65%1.34B-9.91%1.24B5.51%1.38B
Net income continuous operations 20.94%2.71B-0.47%2.24B-5.07%2.25B12.96%2.38B9.58%2.1B10.98%1.92B29.27%1.73B7.65%1.34B-9.91%1.24B5.51%1.38B
Noncontrolling interests 44.00%72M50M
Net income attributable to the company 20.42%2.64B-2.69%2.19B-5.07%2.25B12.96%2.38B9.58%2.1B10.98%1.92B29.27%1.73B7.65%1.34B-9.91%1.24B5.51%1.38B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 20.42%2.64B-2.69%2.19B-5.07%2.25B12.96%2.38B9.58%2.1B10.98%1.92B29.27%1.73B7.65%1.34B-9.91%1.24B5.51%1.38B
Diluted earnings per share 20.22%5.47-5.41%4.55-7.85%4.8112.67%5.229.37%4.63310.83%4.23630.13%3.8229.22%2.937-8.01%2.6898.22%2.923
Basic earnings per share 20.31%5.45-5.62%4.53-7.87%4.812.89%5.219.20%4.61510.95%4.22629.96%3.8099.24%2.931-8.21%2.6838.62%2.923
Dividend per share 7.32%2.46265.21%2.29464.44%2.18110.47%2.08826.37%1.890219.32%1.77713.06%1.48934.02%1.317211.61%1.26637.29%1.1345
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data

Investment Theme Healthcare - Cancer Research
Healthcare - Cancer Research
Intraday+0.74%